Dose-Finding Safety Study of BIIB014 in Early-Stage Parkinson's Disease

NCT00442780 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
36
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Biogen